The markets on February 25, 2019 opened gap up. BSE Sensex is trading at 36,091.59, up by 220.11 points and the Nifty is trading at 10,849.55, up by 57.90 points. 

Gemcitabine injection is used in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer and pancreatic cancer. As per IQVIA, the market for the injection is approx US$11.7 million.

The said acquisition would enhance synergies for the JBM Group with new products, global customers and new German technologies. This would help JBM Auto expand its footprints in the global market.

Aurionpro Solutions’ subsidiaries in Singapore and Thailand have bagged two prestigious projects each in the banking and fintech space. The order wins pertain to the company’s transaction banking product called iCashpro+.

Real estate stocks were buzzing during the morning session on Monday as the GST Council decided on Sunday to cut GST rates applicable on under-construction houses and affordable housing segment.

Many avail loans to cover some of their expenses. Loan against MFs is one of the ways you can take a loan. But should you take it? Let’s find out.

Chinese telecom gear maker Huawei expects India to become the second largest 5G market in the next 10 years. Huawei has partnered with Vodafone Idea and Bharti Airtel for 5G trials.

Overall volumes in futures & options currently stand at 73.74 lakhs contracts with a turnover of Rs. 4,64,334.36 crore.

Overall volumes in futures & options currently stand at 73.74 lakhs contracts with a turnover of Rs. 4,64,334.36 crore.

Going ahead, the levels of 10,820, followed by 10,860, are likely to act as a resistance levels as the crucial moving averages are placed around these levels and unless Nifty trades decisively above these levels we do not expect any major upmove. Stocks in news: Jubilant Life Sciences, Adani Port, Manappuram Finance, Jet Airways, Sharon Bio-Medicine, NTPC, Adani Power, Corporation Bank, Motilal Oswal Financial Services and IIFL Holdings.